Claims for Patent: 6,582,404
✉ Email this page to a colleague
Summary for Patent: 6,582,404
Title: | Dose setting limiter |
Abstract: | A limiting mechanism which prevents the setting of a dose, which exceeds the amount of liquid left in a cartridge of an injection device, is disclosed. The injection device is the type where a dose is set by rotating a dose setting member relative to a driver and away from a fixed stop in the injection device. The dose setting member interfaces the driver such that the dose setting member can be rotated in one direction without rotating the driver. The dose is injected by rotating back the dose setting member which during the backward rotation carries the driver with it. Rotating the driver causes the piston rod to move forward inside the cartridge and expel some of the liquid contained in the cartridge. The driver is provided with a track having a length which is related to the total amount of liquid in the cartridge and which track is engaged by a track follower coupled to the dose setting member to follow rotation of this dose setting member. Each time a dose is set and injected, the track follower moves further into the track. When the track follower reaches the end of the track the dose setting member can not be rotated further, and a dose larger than the remaining liquid in the cartridge cannot be set. |
Inventor(s): | Klitgaard; Peter Christian (Sm.o slashed.rum, DK), Hansen; Steffen (Hiller.o slashed.d, DK), Radmer; Bo (Hiller.o slashed.d, DK), M.o slashed.ller; Claus Schmidt (Fredensborg, DK) |
Assignee: | NNA/S (Bagsvaerd, DK) |
Application Number: | 09/655,922 |
Patent Claims: | 1. A limiting mechanism that prevents setting of a dose that exceeds the amount of liquid left in a cartridge of an injection device wherein a dose is set by rotating a dose
setting member relative to a driver and away from a fixed stop in the injection device, and the dose is injected by rotating back the dose setting member which during this rotation carries the driver with it to rotate this driver which moves the piston
rod forward, wherein the driver is provided with a track having a length which is related to the total amount of medicament in the cartridge and which track is engaged by a track follower coupled to the dose setting member to follow rotation of this dose
setting member and wherein the driver is disk shaped and the track has a spiral shape which is engaged by the track follower which is flexibly coupled to the dose setting member so that the track follower can be moved radially when it follows the track
of the driver element.
2. A limiting mechanism that prevents setting of a dose that exceeds the amount of liquid left in a cartridge of an injection device wherein a dose is set by rotating a dose setting member relative to a driver and away from a fixed stop in the injection device, and the dose is injected by rotating back the dose setting member which during this rotation carries the driver with it to rotate this driver which moves the piston rod forward, wherein the driver is provided with a track having a length which is related to the total amount of medicament in the cartridge and which track is engaged by a track follower coupled to the dose setting member to follow rotation of this dose setting member and wherein the driver is cylindrical and the track has a helical shape which is engaged by the track follower which is coupled to the dose setting member so that the track follower can be moved rotationally when it follows the track of the driver element. 3. The limiting mechanism of claim 2, wherein the dose setting element is a cylinder concentric with the driver. 4. The limiting mechanism of claim 3, wherein the track comprises a thread in the driver and that the track follower comprises a nut shaped member coupled to the dose setting member and provided with a thread engaging the thread of the driver. |
Details for Patent 6,582,404
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | 06/07/2000 | ⤷ Try a Trial | 2019-09-16 |
Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | 01/19/2001 | ⤷ Try a Trial | 2019-09-16 |
Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | 04/23/2004 | ⤷ Try a Trial | 2019-09-16 |
Novo Nordisk Inc. | NOVOLOG | insulin aspart | Injection | 020986 | 10/31/2013 | ⤷ Try a Trial | 2019-09-16 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,582,404
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 299728 | ⤷ Try a Trial |
Austria | 452669 | ⤷ Try a Trial |
Australia | 6820500 | ⤷ Try a Trial |
Australia | 778714 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.